Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Oxygen Therapy Market: By Product: Oxygen Source Equipment, Oxygen Delivery Devices; By Application: Chronic Obstructive Pulmonary Disease, Asthma, Others; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Oxygen Therapy Market Outlook
The global oxygen therapy market attained a value of about USD 11 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 9.1% to reach nearly USD 17 billion by 2026.
Rise of Chronic Respiratory Diseases Owing to Surging Pollution and Tobacco Smoking Aiding the Market Growth
According to the World Health Organisation (WHO), more than 1 billion people in the world suffer from chronic respiratory issues. The rising cases of chronic obstructive pulmonary disease (COPD) caused by rising pollution levels and tobacco smoking are increasing the demand for supplement oxygen to improve survival chances and improve the quality of life of the patients. This is augmenting the growth of the oxygen therapy industry. Moreover, the rising awareness regarding hypoxaemia, which is one of the leading causes of child deaths worldwide, requires the use of supplement oxygen and is further boosting the market growth. The increasing efforts by UNICEF to provide oxygen concentrators in various countries are also aiding the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing geriatric population in Europe who are more prone to respiratory problems is providing further impetus to the market growth. Moreover, the introduction of favourable government incentives to aid the treatment of chronic illness and provide required supplement oxygen are further invigorating the market growth. Furthermore, increasing innovations to provide personalised and efficient oxygen therapy at home is also fuelling the industry growth. The market in North America is rapidly growing owing to escalating research and development (R&D) and the adoption of the latest technological advancements by the leading companies. Moreover, they are investing in digital marketing and expanding their online presence, which is also accelerating the industry growth, further contributing to the overall market growth.
Oxygen Therapy: Industry Definition and Segmentation
Oxygen therapy, variously known as supplement oxygen, is a treatment that provides oxygen to patients with breathing disorders. It aids in improving the energy level, sleep, and quality of life of patients. Oxygen can be supplied through various ways, including face masks, nasal cannula, and bag valve masks, among others.
Based on the products, the market is divided into:
- Oxygen Source Equipment
- Oxygen Cylinders
- Oxygen Concentrators
- Liquid Oxygen Devices
- PAP Devices
- Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannula
- Venturi Masks
- Non-Rebreather Masks
- Bag Valve Masks
- CPAP Masks
- Others
The major applications of oxygen therapy are:
- Chronic Obstructive Pulmonary Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Others
The market can be broadly categorised on the basis of its end uses into:
- Home Healthcare
- Hospitals
The EMR report looks into the regional markets of oxygen therapy like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.
Growing Cases of Pneumonia Owing to the Second Wave of the Coronavirus Pandemic to Bolster the Market Growth
The demand for oxygen therapy is increasing significantly due to the surge of the coronavirus pandemic. As COVID-19 can lead to pneumonia and make it difficult or impossible to breathe, patients require supplement oxygen, which is augmenting the market growth. The escalating demand for oxygen supplements in hospitals due to the pandemic is further aiding the market. Moreover, the development of COVID speciality hospitals in various countries to contain the virus is also increasing the demand for oxygen therapy, consequently propelling the market growth. In addition, the growing demand for portable oxygen concentrators for patients in home isolation is further driving the market growth.
The surge of the second wave of the pandemic in various countries, such as India, Laos, Nepal, Singapore, South Africa, and Cambodia, among others, is resulting in the mutations of the virus and the development of deadlier strains, which, in turn, is increasing the demand for oxygen supplements, consequently facilitating the market growth. The increasing investments by the governments and major companies to aid the demand for oxygen cylinders and concentrators are also boosting the market growth. Moreover, with the rising technological advancements and the adoption of innovative practices, major companies are developing superior oxygen therapy for home healthcare. The companies are investing in research and development (R&D) to develop cost-effective, disposable, risk-free, and advanced products for oxygen therapy. This is expected to catalyse the market growth further.
Key Industry Players in the Global Oxygen Therapy Market
The report presents a detailed analysis of the following key players in the global oxygen therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Hersill S.L.
- Philips Respironics, Inc.
- DeVilbiss Healthcare LLC
- Smiths Group plc
- Teleflex Incorporated
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region |
| Breakup by Product | Oxygen Source Equipment, Oxygen Delivery Devices |
| Breakup by Application | Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Others |
| Breakup by End Use | Home Healthcare, Hospitals |
| Breakup by Regions | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Hersill S.L., Philips Respironics, Inc., DeVilbiss Healthcare LLC, Smiths Group plc, Teleflex Incorporated, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Oxygen Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Oxygen Therapy Historical Market (2017-2021)
8.3 Global Oxygen Therapy Market Forecast (2022-2027)
8.4 Global Oxygen Therapy Market by Product
8.4.1 Oxygen Source Equipment
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.1.4 Breakup by Equipment Type
8.4.1.4.1 Oxygen Cylinders
8.4.1.4.1.1 Market Share
8.4.1.4.1.2 Historical Trend (2017-2021)
8.4.1.4.1.3 Forecast Trend (2022-2027)
8.4.1.4.2 Oxygen Concentrators
8.4.1.4.2.1 Market Share
8.4.1.4.2.2 Historical Trend (2017-2021)
8.4.1.4.2.3 Forecast Trend (2022-2027)
8.4.1.4.3 Liquid Oxygen Devices
8.4.1.4.3.1 Market Share
8.4.1.4.3.2 Historical Trend (2017-2021)
8.4.1.4.3.3 Forecast Trend (2022-2027)
8.4.1.4.4 PAP Devices
8.4.1.4.4.1 Market Share
8.4.1.4.4.2 Historical Trend (2017-2021)
8.4.1.4.4.3 Forecast Trend (2022-2027)
8.4.2 Oxygen Delivery Devices
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.2.4 Breakup by Devices
8.4.2.4.1 Oxygen Masks
8.4.2.4.1.1 Market Share
8.4.2.4.1.2 Historical Trend (2017-2021)
8.4.2.4.1.3 Forecast Trend (2022-2027)
8.4.2.4.2 Nasal Cannula
8.4.2.4.2.1 Market Share
8.4.2.4.2.2 Historical Trend (2017-2021)
8.4.2.4.2.3 Forecast Trend (2022-2027)
8.4.2.4.3 Venturi Masks
8.4.2.4.3.1 Market Share
8.4.2.4.3.2 Historical Trend (2017-2021)
8.4.2.4.3.3 Forecast Trend (2022-2027)
8.4.2.4.4 Non-Rebreather Masks
8.4.2.4.4.1 Market Share
8.4.2.4.4.2 Historical Trend (2017-2021)
8.4.2.4.4.3 Forecast Trend (2022-2027)
8.4.2.4.5 Bag Valve Masks
8.4.2.4.5.1 Market Share
8.4.2.4.5.2 Historical Trend (2017-2021)
8.4.2.4.5.3 Forecast Trend (2022-2027)
8.4.2.4.6 CPAP Masks
8.4.2.4.6.1 Market Share
8.4.2.4.6.2 Historical Trend (2017-2021)
8.4.2.4.6.3 Forecast Trend (2022-2027)
8.4.2.4.7 Others
8.5 Global Oxygen Therapy Market by Application
8.5.1 Chronic Obstructive Pulmonary Disease
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Asthma
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Obstructive Sleep Apnea
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Respiratory Distress Syndrome
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Cystic Fibrosis
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Others
8.6 Global Oxygen Therapy Market by End Use
8.6.1 Home Healthcare
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Hospitals
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.7 Global Oxygen Therapy Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Hersill S.L.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Philips Respironics, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 DeVilbiss Healthcare LLC
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Smiths Group plc
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Teleflex Incorporated
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global Oxygen Therapy Market: Key Industry Highlights, 2016 and 2026
2. Global Oxygen Therapy Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global Oxygen Therapy Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global Oxygen Therapy Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Oxygen Therapy Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Oxygen Therapy Historical Market: Breakup by End Use (USD Million), 2017-2021
7. Global Oxygen Therapy Market Forecast: Breakup by End Use (USD Million), 2022-2027
8. Global Oxygen Therapy Historical Market: Breakup by Region (USD Million), 2017-2021
9. Global Oxygen Therapy Market Forecast: Breakup by Region (USD Million), 2022-2027
10. North America Oxygen Therapy Historical Market: Breakup by Country (USD Million), 2017-2021
11. North America Oxygen Therapy Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Europe Oxygen Therapy Historical Market: Breakup by Country (USD Million), 2017-2021
13. Europe Oxygen Therapy Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Asia Pacific Oxygen Therapy Historical Market: Breakup by Country (USD Million), 2017-2021
15. Asia Pacific Oxygen Therapy Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Latin America Oxygen Therapy Historical Market: Breakup by Country (USD Million), 2017-2021
17. Latin America Oxygen Therapy Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Middle East and Africa Oxygen Therapy Historical Market: Breakup by Country (USD Million), 2017-2021
19. Middle East and Africa Oxygen Therapy Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Global Oxygen Therapy Market Structure
Key Questions Answered in the Report
In 2020, the global oxygen therapy market attained a value of nearly USD 11 billion.
The market is projected to grow at a CAGR of 9.1% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 17 billion by 2026.
The market is being aided by the rising cases of chronic respiratory diseases, which requires supplement oxygen for the wellbeing of patients.
The market is driven by increasing research and development (R&D) by the leading players, the rising prevalence of portable oxygen concentrators, and the surging cases of pneumonia during the coronavirus pandemic.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of oxygen therapy in the industry are oxygen source equipment and oxygen delivery devices.
The dominant applications of oxygen therapy are chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, and cystic fibrosis, among others.
The significant end uses in the market are home healthcare and hospitals.
The major players in the industry are Hersill S.L., Philips Respironics, Inc., DeVilbiss Healthcare LLC, Smiths Group plc, and Teleflex Incorporated, among others.
Analyst Review
The global oxygen therapy market attained a value of about USD 11 billion in 2020, driven by the rising prevalence of respiratory chronic diseases. Aided by the growing research and development (R&D) activities, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 9.1%. The market is projected to reach USD 17 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the oxygen therapy industry can be segmented into oxygen source equipment and oxygen delivery devices. By applications, the market is categorised into chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, and cystic fibrosis, among others. On the basis of end uses, the industry is divided into home healthcare and hospitals. The major regional markets for oxygen therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Hersill S.L., Philips Respironics, Inc., DeVilbiss Healthcare LLC, Smiths Group plc, and Teleflex Incorporated, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global thrombin market attained a value of more than USD 578.5 million in 2021, driven by the rising cases of haemophilia. Aided by the technological advancements in the healthcare industry in the...
The global transcatheter pulmonary valve market is expected to grow at a CAGR of 7.4% during the period 2022-2027.
The global PD-1 and PD-L1 inhibitors market attained a value of USD 30.3 billion in 2021, driven by the rising incidences of cancer. Aided by the growing geriatric population and favourable government...
The global biosurgery market attained a value of more than USD 13.4 billion in 2021, driven by the prevalence of different biosurgeries. Aided by advancements in healthcare structure, the market is ex...
The global albumin market attained a value of USD 5.3 billion in 2021, driven by the rising benefits of HSA on commercial and therapeutic applications. Aided by advancements in nanotechnology for drug...
NEWSLETTER